Immunovant IMVT
NASDAQ IMVT
$28.24 -0.35 (-1.22%)
As of: Oct 21, 2026 · 2:49 PM EDT

Immunovant (IMVT) EBITDA Margin (2022 - 2026)

Updated

Analysis

Immunovant (IMVT) EBITDA Margin (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 35.95%
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn 49.01%
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 33.11%
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -124.26%
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn 39.16%
10 Immunovant 5.81 Bn 2.59 Bn - -2,158.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,158.31%
Mar 31, 2026 -1,869.46%
Dec 31, 2025 -2,043.54%
Sep 30, 2025 -2,244.88%
Jun 30, 2025 -1,887.22%
Mar 31, 2025 -1,535.38%
Dec 31, 2024 -2,415.49%
Sep 30, 2024 -1,794.04%
Jun 30, 2024 -1,211.60%
Mar 31, 2024 -895.37%
Dec 31, 2023 -576.16%
Sep 30, 2023 -1,628.00%
Jun 30, 2023 -1,817.84%
Mar 31, 2023 -1,734.74%
Dec 31, 2022 -2,132.85%
Sep 30, 2022 -4,126.60%
API Access

Immunovant EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMVT&period=max&api_key=YOUR_API_KEY